课题基金 / 基金详情

项目摘要

项目成果

KEVIN J. CULLEN的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY (See instructions); The Flow Cytometry Shared Service (FCSS) at the University of Maryland Marlene and Stewart Greenebaum Cancer Center (UMGCC) offers flow cytometry equipment and technical expertise to UMGCC members conducting research in cancer biology and other areas of basic and applied science. Services are open to the entire University of Maryland campus, but UMGCC accounts for about 75 percent of the total use. FCSS provides full scale, state-of-the-art flow cytometry services, from functional and phenotypic analysis to cell sorting. Analytical instruments include a modern, fully digital, 3-laser Becton Dickinson (BD) LSR II flow cytometer, and two analog flow cytometers: a BD LSR 1 and a BD FACScan instrument. Cell sorting is conducted with (1) a BD FACSAria I digital instrument equipped with two lasers and seven-colordetection capability and (2) a BD FACSVantage SE instrument upgraded with BD's Digital Acquisition System (DIVA) and equipped with three lasers including a tunable krypton laser for 351 nm ultraviolet excitation. FCSS also offers users both operator-assisted and self-service data analysis on several platforms as well as experimental training and consultation to support project design for individual analytical or sorting experiments. The effectiveness of FCSS is evident from the steady increase of its utilization in recent years, the more than 50 principal investigators who are using the shared service, and the number of publications and National Cancer Institute-funded projects supported by experiments conducted with the help ofthe shared service. The goal of FCSS is to further increase the breadth and scope of its services by expanding cell-sorting capabilities; supporting novel, flow cytometry-based analytical applications; and strengthening cooperation with other UMGCC shared sen/ices to help introduce innovative, cutting-edge technologies to UMGCC investigators.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Targeting PI3Kalpha beta and the ErbB family of protein-tyrosine kinases in cisplatin-resistant head and neck squamous cell carcinomas (HNSCC)
  • 批准号:
    10667253
  • 项目类别:
  • 资助金额:
    $37.63万
  • 财政年份:
    2022
  • 负责人:
    KEVIN J. CULLEN
  • 依托单位:
Program Leaders of Research Programs
  • 批准号:
    8711295
  • 项目类别:
  • 资助金额:
    $8.21万
  • 财政年份:
    2014
  • 负责人:
    KEVIN J. CULLEN
  • 依托单位:
Cancer Center Administration
  • 批准号:
    8711298
  • 项目类别:
  • 资助金额:
    $9.74万
  • 财政年份:
    2014
  • 负责人:
    KEVIN J. CULLEN
  • 依托单位:
Program Leaders
  • 批准号:
    8340231
  • 项目类别:
  • 资助金额:
    $8.47万
  • 财政年份:
    2011
  • 负责人:
    KEVIN J. CULLEN
  • 依托单位:
海外基金